VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-0.88%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.79M
Cap. Flow %
-2.99%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

1
XFLT
XAI Octagon Floating Rate and Alternative Income Trust
XFLT
$663K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
$469K
4
EFT
Eaton Vance Floating-Rate Income Trust
EFT
$425K
5
ENIC icon
Enel Chile
ENIC
$406K

Top Sells

1
GRA
W.R. Grace & Co.
GRA
$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
$693K
4
NOA
North American Construction
NOA
$569K
5
MCI
Barings Corporate Investors
MCI
$524K

Sector Composition

1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BDTX icon
351
Black Diamond Therapeutics
BDTX
$167M
$140K 0.06%
16,600
-862
-5% -$7.27K
FATE icon
352
Fate Therapeutics
FATE
$116M
$140K 0.06%
2,356
-130
-5% -$7.73K
STOK icon
353
Stoke Therapeutics
STOK
$1.13B
$140K 0.06%
5,502
-284
-5% -$7.23K
IBRX icon
354
ImmunityBio
IBRX
$2.27B
$139K 0.06%
14,244
-738
-5% -$7.2K
VSTM icon
355
Verastem
VSTM
$663M
$138K 0.06%
3,746
-195
-5% -$7.18K
DNTH icon
356
Dianthus Therapeutics
DNTH
$853M
$136K 0.06%
1,169
-61
-5% -$7.1K
CDAK
357
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$136K 0.06%
8,316
-439
-5% -$7.18K
RCKT icon
358
Rocket Pharmaceuticals
RCKT
$354M
$135K 0.06%
4,506
-228
-5% -$6.83K
MRSN icon
359
Mersana Therapeutics
MRSN
$34M
$134K 0.06%
567
-29
-5% -$6.85K
RYTM icon
360
Rhythm Pharmaceuticals
RYTM
$6.78B
$134K 0.06%
10,229
-536
-5% -$7.02K
RUBY
361
DELISTED
Rubius Therapeutics, Inc
RUBY
$134K 0.06%
7,478
-390
-5% -$6.99K
KALV icon
362
KalVista Pharmaceuticals
KALV
$796M
$131K 0.06%
7,494
-399
-5% -$6.98K
TCRT icon
363
Alaunos Therapeutics
TCRT
$4.27M
$131K 0.06%
480
-26
-5% -$7.1K
GMDA
364
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$130K 0.06%
33,121
-1,721
-5% -$6.76K
TARS icon
365
Tarsus Pharmaceuticals
TARS
$2.43B
$129K 0.06%
6,008
-311
-5% -$6.68K
MRNS
366
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$129K 0.06%
11,335
-595
-5% -$6.77K
BCEL
367
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$128K 0.06%
20,473
-1,077
-5% -$6.73K
ADVM icon
368
Adverum Biotechnologies
ADVM
$73.9M
$125K 0.06%
5,777
-302
-5% -$6.54K
GTHX
369
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$125K 0.06%
9,343
-489
-5% -$6.54K
ATNX
370
DELISTED
Athenex, Inc. Common Stock
ATNX
$125K 0.06%
2,072
-108
-5% -$6.52K
TECX
371
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
$124K 0.05%
1,854
-96
-5% -$6.42K
CVAC icon
372
CureVac
CVAC
$1.21B
$117K 0.05%
2,150
-109
-5% -$5.93K
DRNA
373
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$113K 0.05%
5,581
-299
-5% -$6.05K
AMTI
374
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$112K 0.05%
4,332
-233
-5% -$6.02K
CVM icon
375
CEL-SCI Corp
CVM
$72.2M
$109K 0.05%
332
-17
-5% -$5.58K
13 14
15
16 17